IBIO

Value 20202021202220232024 TTM Total revenue 2.37 M2.38 M0225 K400 K 300 K Gross profit 909 K2.17 M0225 K400 K 300 K Operating expenses 32.02 M51.86 M29.34 M16.86 M19 M 25.77 M Selling/general/admin expenses 22.03 M34.13 M19.02 M11.67 M10.69 M 12.81 M Research & development 9.99 M17.73 M10.33 M5.18 M8.31 M 12.96 M Operating income 31.11 M49.69 M29.34 M16.63 M18.6 M 25.47 M Non-Operating Income, Total 7.9 M614 K32 K1.19 M225 K 736 K Interest expense, net of interest capitalized 2.45 M1.41 M83 K172 K212 K 175 K Non-Operating Income, excl. Interest Expenses 5.44 M-804 K-51 K1.02 M13 K 561 K Unusual income/expense —6 000——— — Pretax income 34.12 M49.18 M29.26 M18.46 M18.61 M 26.03 M Equity in earnings ————— — Taxes 00000 0 Non-controlling/minority interest 6 0001 000——— — After tax other income/expense ————— — Net income before discontinued operations 23.21 M50.3 M29.31 M15.44 M8.91 M 19.67 M Discontinued operations ——35.7 M9.46 M9.46 M — Net income 23.21 M50.3 M65.01 M24.91 M18.38 M 24.74 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 23.47 M50.39 M29.31 M24.91 M18.38 M 24.69 M Basic earnings per share (Basic EPS) —-115.6-106.2-6.5-1.75 -1.01 Diluted earnings per share (Diluted EPS) —-115.6-106.2-6.5-1.75 -1.01 Average basic shares outstanding —436.05 K612.25 K3.83 M10.5 M 172.47 M Diluted shares outstanding —436.05 K612.25 K3.83 M10.5 M 172.47 M EBITDA -28.48 M-46.1 M——— — EBIT -31.11 M-49.69 M——— — Cost of revenue 1.46 M216 K——— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 2.63 M3.59 M1.09 M1.05 M775 K 9.73 M